Cardiovascular diseases (CVDs) are the number 1 cause of death globally. An estimated 17.9 million people died from cardiovascular diseases in 2016 representing 31% of all global deaths in 2016. Out of these, 85% were due to heart attack and stroke. According to the American Heart Association, a new clinical study has suggested that Tocotrienols from Annatto may enhance cardiovascular benefits. A Canadian company, Eannatto has successfully harvested Annatto for Tocotrienols to deliver it to every corner of the world to provide maximum health benefits.
Cholesterol reduction is a significant feature of Tocotrienols by suppression of HMGR (3-hydroxy3methyl-glutaryl-CoA reductase) the enzyme/protein responsible for the body’s cholesterol production.
Cytokines associated with cardiovascular diseases were down-regulated by Tocotrienols according to the study done at the University of Missouri – Kansas City.
MicroRNAs which are usually down-regulated in hyper-cholesterolemic individuals are up-regulated by Tocotrienol treatment as per the study.
Cellular adhesion molecule expression
Cellular adhesion molecule expression has been observed to be reduced by Tocotrienols.
Monocytic cell adherence
Monocytic cell adherence has also been found to be reduced by Tocotrienol in multiple kinds of research
‘Velcro effect”, a process which initiates plaque formation in arterial walls has also been observed to be reduced by Tocotrienol.
Lipid peroxides in blood vessels and blood pressure have been observed to be lowered by Tocotrienols which improves total anti-oxidant status thus preventing hypertension.
Carotid Arteriosclerosis has been observed to be reduced by Tocotrienol in several studies.
Anti-inflammation are characteristic properties of Tocotrienols.